Studies using melanoma cell lines revealed that the suppression of ASS1 expression is due to Hif1α binding to the promoter region of ASS1, but this suppression can be relieved under ADT by induced downregulation of Hif1α and binding of upregulated c-Myc to replace Hif1α. The gene discussed is ASS1; the disease is melanoma.